For the study, researchers from University of California Irvine, Bethesda, Md.-based National Cancer Institute, South Salem, N.Y.-based non-profit Global Focus on Cancer, Australia and Cyprus reviewed 36 studies, predominantly from the U.S. between January 2002 and May 2024, for patient-relevant outcomes including mortality, survival, care quality, recurrence and quality of life.
Here are four takeaways from their findings:
- Studies consistently reported superior mortality and survival outcomes, care quality, rates of cancer recurrence or progression, symptoms and quality of life from NCI-designated comprehensive cancer centers compared to non-designated centers.
- Non-designated centers had more favorable outcomes in studies that focused on health equity and cost.
- Results were mixed for three outcomes: time to care, palliative and end-of-life care, and health care utilization.
- “Rather than aiming for superior outcomes, comprehensive cancer centers should be striving to enable equitable, high value, patient-centered outcomes for all people affected by cancer,” the authors of the study wrote.
At the Becker's Perioperative Summit, taking place September 14–15 in Chicago, perioperative leaders and healthcare executives will focus on improving operating room efficiency, enhancing patient safety, optimizing staffing and driving innovation across surgical services. Apply for complimentary registration now.
